PISKEL KYLE
SEC CIK 1780662 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ADPT | Adaptive Biotechnologies Corp | Principal Accounting Off | 256.7K | — | $3.76M | 28 | 2021-11-15 | 2026-05-18 |
Most active insiders at ADPT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | ROBINS CHAD M | CEO, COB, Dir | — | $39.80M |
| 2 | ROBINS HARLAN S | CSO | — | $29.65M |
| 3 | BENZENO SHARON | Chief Commercial Ofc Imm Med | — | $14.69M |
| 4 | RUBINSTEIN JULIE | Pres, COO | — | $13.37M |
| 5 | LO FRANCIS | CHRO | — | $13.21M |
| 6 | PISKEL KYLE | CFO | — | $3.58M |
| 7 | NEUPERT PETER M | Dir | — | $3.14M |
| 8 | GRIFFIN MICHELLE RENEE | Dir | — | $2.00M |
| 9 | BOBULSKY SUSAN | Chief Commercial Off, MRD | — | $1.20M |
| 10 | HERSHBERG ROBERT | Dir | — | $1.12M |
Transactions 28
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-20 19:13 | 2026-05-18 | ADPT | Adaptive Biotechnologies Corp | PISKEL KYLE | CFO | S - Sale | $13.04 | -3,115 | 256.7K | -1% | -$40.6K | |
| 2026-03-13 | 2026-03-11 | ADPT | Adaptive Biotechnologies Corp | PISKEL KYLE | CFO | S - Sale | $13.17 | -18.7K | 259.8K | -7% | -$245.9K | |
| 2026-03-06 | 2026-03-04 | ADPT | Adaptive Biotechnologies Corp | PISKEL KYLE | CFO | A - Grant | $0.00 | +61.9K | 278.5K | +29% | $0 | |
| D | 2026-02-06 | 2026-02-04 | ADPT | Adaptive Biotechnologies Corp | PISKEL KYLE | CFO | S - Sale+OE | $18.46 | -2,145 | 216.6K | -1.0% | -$39.6K |
| D | 2026-02-06 | 2026-02-04 | ADPT | Adaptive Biotechnologies Corp | PISKEL KYLE | CFO | M - OptEx | $12.14 | +2,145 | 218.8K | +1.0% | +$26.0K |
| D | 2026-01-14 | 2026-01-12 | ADPT | Adaptive Biotechnologies Corp | PISKEL KYLE | CFO | M - OptEx | $12.14 | +4,290 | 220.9K | +2% | +$52.1K |
| D | 2026-01-14 | 2026-01-12 | ADPT | Adaptive Biotechnologies Corp | PISKEL KYLE | CFO | S - Sale+OE | $18.00 | -4,290 | 216.6K | -2% | -$77.2K |
| D | 2025-12-02 | 2025-11-28 | ADPT | Adaptive Biotechnologies Corp | PISKEL KYLE | CFO | S - Sale+OE | $19.50 | -162.8K | 216.6K | -43% | -$3.17M |
| DM | 2025-12-02 | 2025-11-28 | ADPT | Adaptive Biotechnologies Corp | PISKEL KYLE | CFO | M - OptEx | $11.38 | +110.1K | 285.1K | +63% | +$1.25M |
| 2025-11-18 | 2025-11-17 | ADPT | Adaptive Biotechnologies Corp | PISKEL KYLE | CFO | S - Sale | $14.05 | -238 | 269.3K | -0.1% | -$3,344 | |
| A | 2025-05-20 | 2025-05-16 | ADPT | Adaptive Biotechnologies Corp | PISKEL KYLE | CFO | S - Sale | $8.89 | -1,929 | 269.6K | -0.7% | -$17.1K |
| 2025-05-19 | 2025-05-16 | ADPT | Adaptive Biotechnologies Corp | PISKEL KYLE | CFO | S - Sale | $8.89 | -1,929 | 277.4K | -0.7% | -$17.1K | |
| 2025-05-19 | 2025-05-15 | ADPT | Adaptive Biotechnologies Corp | PISKEL KYLE | CFO | A - Grant | $0.00 | +7,815 | 279.3K | +3% | $0 | |
| D | 2025-03-17 | 2025-03-14 | ADPT | Adaptive Biotechnologies Corp | PISKEL KYLE | CFO | M - OptEx | $6.32 | +2,500 | 271.5K | +0.9% | +$15.8K |
| M | 2025-03-06 | 2025-03-05 | ADPT | Adaptive Biotechnologies Corp | PISKEL KYLE | CFO | S - Sale | $6.98 | -10.3K | 276.0K | -4% | -$72.1K |
| 2025-03-06 | 2025-03-04 | ADPT | Adaptive Biotechnologies Corp | PISKEL KYLE | CFO | A - Grant | $0.00 | +125.0K | 279.3K | +81% | $0 | |
| 2024-11-19 | 2024-11-18 | ADPT | Adaptive Biotechnologies Corp | PISKEL KYLE | CFO | S - Sale | $4.98 | -248 | 154.3K | -0.2% | -$1,235 | |
| 2024-05-17 | 2024-05-15 | ADPT | Adaptive Biotechnologies Corp | PISKEL KYLE | CFO | A - Grant | $0.00 | +31.3K | 154.6K | +25% | $0 | |
| 2024-03-06 | 2024-03-04 | ADPT | Adaptive Biotechnologies Corp | PISKEL KYLE | Principal Accounting Off | A - Grant | $0.00 | +43.7K | 131.0K | +50% | $0 | |
| 2024-03-06 | 2024-03-05 | ADPT | Adaptive Biotechnologies Corp | PISKEL KYLE | Principal Accounting Off | S - Sale | $3.43 | -7,727 | 123.3K | -6% | -$26.5K | |
| 2023-11-20 | 2023-11-16 | ADPT | Adaptive Biotechnologies Corp | PISKEL KYLE | Principal Accounting Off | S - Sale | $4.13 | -259 | 87.3K | -0.3% | -$1,070 | |
| M | 2023-03-08 | 2023-03-06 | ADPT | Adaptive Biotechnologies Corp | PISKEL KYLE | Principal Accounting Off | S - Sale | $8.57 | -3,529 | 87.6K | -4% | -$30.2K |
| 2023-03-08 | 2023-03-06 | ADPT | Adaptive Biotechnologies Corp | PISKEL KYLE | Principal Accounting Off | A - Grant | $0.00 | +43.7K | 91.1K | +92% | $0 | |
| A | 2022-11-17 | 2022-11-16 | ADPT | Adaptive Biotechnologies Corp | PISKEL KYLE | Principal Accounting Off | S - Sale | $8.87 | -307 | 47.4K | -0.6% | -$2,723 |
| 2022-11-17 | 2022-11-16 | ADPT | Adaptive Biotechnologies Corp | PISKEL KYLE | Principal Accounting Off | S - Sale | $8.87 | -959 | 46.7K | -2% | -$8,506 | |
| D | 2022-03-08 | 2022-03-04 | ADPT | Adaptive Biotechnologies Corp | PISKEL KYLE | Principal Accounting Off | A - Grant | $0.00 | +41.2K | 47.9K | +615% | $0 |
| D | 2022-03-08 | 2022-03-07 | ADPT | Adaptive Biotechnologies Corp | PISKEL KYLE | Principal Accounting Off | S - Sale | $12.01 | -220 | 47.7K | -0.5% | -$2,642 |
| D | 2021-11-17 | 2021-11-15 | ADPT | Adaptive Biotechnologies Corp | PISKEL KYLE | Principal Accounting Off | A - Grant | $0.00 | +3,837 | 6,699 | +134% | $0 |
Purchase Sale Sale after option exercise All abbreviations